NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
23.32
+0.74 (3.28%)
At close: Sep 22, 2026, 4:00 PM EDT
22.96
-0.36 (-1.55%)
Pre-market: Sep 23, 2026, 6:06 AM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.79 billion as of September 22, 2026. Its market cap has decreased by -7.27% in one year.
Market Cap
2.79B
Enterprise Value
2.11B
1-Year Change
-7.27%
Ranking
Category
Stock Price
$23.32
ChartMarket Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.79B, an increase of 1,704.87%. That is a compound annual growth rate of 67.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 2.79B | -29.92% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.91B |
| Precigen | 2.82B |
| Nurix Therapeutics | 2.66B |
| Structure Therapeutics | 2.64B |
| Disc Medicine | 2.62B |
| Beam Therapeutics | 2.60B |
| Celldex Therapeutics | 2.59B |
| Vera Therapeutics | 2.57B |